VCYT, Veracyte, Inc

"Loading Stock Price & Valuation Data ..."

Agentic AI (Pro) Picks for VCYT

History

Run pick agents

Subscribe to iPick.ai (Pro) to use Power Picks, Hidden-Gem Picks, Bear Picks, and more.


Short Seller Reports & Red Flags:

News Summary: Subscribe

Unlock News Summary by Subscribing to iPick.ai Premium!





Unlock Ask VCYT by Subscribing to iPick.ai Premium!



Stock Chart



Competitors:

(CRIS) Curis, Inc

Latest YouTube Video:

Unlock YouTube Video by Subscribing to iPick.ai Premium!



Billionaire Connection

Not available

Business Profile

Address: 6000 Shoreline Court, Suite 300, South San Francisco, CA, United States, 94080

Employees: 755

Business Summary

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.

Leadership and Board

Mr. Marc A. Stapley

CEO & Director

Ms. Rebecca Chambers

Executive VP & CFO

Dr. Phillip G. Febbo M.D.

Chief Scientific & Medical Officer

Ms. Annie McGuire

Executive VP, General Counsel & Head of Market Access

Dr. John Leite Ph.D.

Global Chief Commercial Officer

Dr. Keith Gligorich Ph.D.

Senior Vice President of Global Operations

Mr. Jonathan Wygant

VP & Chief Accounting Officer

Dr. Kevin Richard Haas Ph.D.

Chief Development & Technology Officer

Mr. Steven French

Senior VP & Chief Information Officer

Ms. Kelly Gura

Director of Investor Relations